S89.112
Salter-Harris Type I physeal fracture of lower end of left tibia
Clinical Classification Guidelines
Medical Intelligence & Overview
A Salter-Harris Type I physeal fracture involves the growth plate (physis) of the bone. Specifically, this condition pertains to a fracture at the lower end of the left tibia, which is the larger bone in the lower leg, just above the ankle. Such fractures are common in children and adolescents whose growth plates have not yet fused. Recognizing this injury early is important for proper treatment and to ensure normal growth of the affected bone.
Causes & Symptoms
Clinical Causes: Twisting injuries, especially during sports activities Falls or direct blows to the lower leg Trauma resulting from car accidents or bicycle falls Sudden impacts during physical activity
Key Symptoms: Pain localized around the lower part of the left tibia near the ankle Swelling and tenderness in the affected area Difficulty bearing weight or walking on the affected leg Bruising or redness around the site of injury Limited range of motion in the ankle joint
Diagnostic & Treatment
Diagnosis Path: The diagnosis typically involves a physical examination coupled with imaging studies. An X-ray is the most common initial test used to identify fractures in the growth plate region. Sometimes, additional imaging such as MRI might be needed to assess the extent of the injury, especially if minor or complex fractures are suspected. Accurate identification of a Salter-Harris Type I fracture helps guide appropriate management to prevent future growth disturbances.
Treatment Protocols: Treatment methods aim to realign the growth plate and allow proper healing. These may include:
Clinical Advice & FAQs
Billing Guidance
Is S89.112 a billable ICD-10 code?
Yes, S89.112 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report S89.112?
Clinical documentation must specify the nature of Salter-Harris Type I physeal fracture of lower end of left tibia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
